ATRY.MC BME
Atrys Health, S.A.
1W: -4.8%
1M: +3.2%
3M: +0.4%
YTD: -12.5%
1Y: -9.2%
3Y: -42.3%
5Y: -76.0%
€2.54 ($2.85)
-0.04 (-1.36%)
Weekly Expected Move ±5.8%
€2
€2
€3
€3
€3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$213M
+5.5% ▲
5Y CAGR: +70.3%
Gross Profit
$145M
+2.5% ▲
5Y CAGR: +64.2%
Operating Income
-$11M
-566.9% ▼
Net Income
-$32M
+30.3% ▲
EPS (Diluted)
$-0.42
+30.0% ▲
EBITDA
$19M
-40.2% ▼
5Y CAGR: +43.2%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $34M | $121M | $158M | $202M | $213M |
| YoY Growth | +127.9% | +257.9% | +30.9% | +27.3% | +5.5% |
| Cost of Revenue | $21M | $20M | $32M | $60M | $67M |
| Gross Profit | $12M | $101M | $24M | $142M | $145M |
| Gross Margin | 36.7% | 83.4% | 15.3% | 70.3% | 68.3% |
| R&D Expenses | $1M | $2M | $2M | $3M | $0 |
| SG&A Expenses | $213K | $28M | $19M | $30M | $2M |
| Operating Expenses | $13M | $116M | $31M | $144M | $156M |
| Operating Income | -$230K | -$15M | -$7M | -$2M | -$11M |
| Operating Margin | -0.7% | -12.4% | -4.4% | -0.8% | -5.0% |
| Interest Expense | $2M | $11M | $15M | $33M | $23M |
| Income Before Tax | -$5M | -$25M | -$24M | -$34M | -$33M |
| Tax Expense | $167K | -$2M | $2M | -$3M | -$2M |
| Net Income | -$6M | -$23M | -$23M | -$46M | -$32M |
| Net Margin | -16.4% | -19.2% | -14.6% | -22.6% | -14.9% |
| EPS (Diluted) | $-0.20 | $-0.43 | $-0.34 | $-0.60 | $-0.42 |
| EBITDA | $7M | $6M | $17M | $32M | $19M |
| Shares Outstanding | 28M | 54M | 68M | 76M | 76M |